Lung cancer screening program using low-dose tomography and metabolomic evaluation in a public service.

Trial Identifier:	D5162R00036
Sponsor:	AstraZeneca
NCTID::	NCT06376097
Start Date:	April 2023
Primary Completion Date:	February 2025
Study Completion Date:	February 2025
Condition:	Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Brazil, São Paulo	Botucatu, São Paulo, Brazil, 18618-686

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.